𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Detection of neutralizing antibodies against human cytomegalovirus: Influence of strain variation

✍ Scribed by Dr. B. Weber; U. Klinghardt; A. Lux; W. Braun; H. Rabenau; H. W. Doerr


Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
655 KB
Volume
40
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The influence of human cytomegalovirus (HCMV) strain variation on neutralizing antibody titers was investigated in sequential sera obtained from 12 organ transplant recipients (11 renal transplant recipients, 1 liver transplant patient) suffering from primary or secondary HCMV infection. Cross‐neutralization assays using either the international HCMV reference strain AD169 or individual clinical isolates from patients showed congruent results. Restriction enzyme analysis of the hypervariable α‐sequence of the L‐S junction of AD169 and HCMV isolates amplified by polymerase chain reaction (PCR) were carried out to confirm the expected strain differences. At least 6 groups of clinical strains were differentiated. The results of this study demonstrated that despite the strain heterogenicity of HCMV, the neutralization assay using AD169 permitted a reliable and quantitative serologic detection of neutralizing antibodies against HCMV. Β© 1993 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


An ELISA using recombinant proteins for
✍ Barbara Kropff; Maria-Paola Landini; Michael Mach πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 827 KB

Two prokaryotically expressed fusion proteins encompassing amino acids 484-650 (AD-I) and 27-100 (AD-2) of glycoprotein gp58/116 of human cytomegalovirus (HCMV) were purified from E. coli lysates and used in ELISA to determine antibody levels in human sera. The specificity of the test was establishe

Generation of potent neutralizing human
✍ Ada Funaro; Giorgio Gribaudo; Anna Luganini; Erika Ortolan; Nicola Lo Buono; Eli πŸ“‚ Article πŸ“… 2008 πŸ› BioMed Central 🌐 English βš– 776 KB

Background: Human monoclonal antibodies (mAbs) generated as a result of the immune response are likely to be the most effective therapeutic antibodies, particularly in the case of infectious diseases against which the immune response is protective. Human cytomegalovirus (HCMV) is an ubiquitous oppo